MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinson’s disease associated psychosis: Prevalence and risk factors

A. Dutt, H. Kumar, M. Mukherjee, M.U. Kulsum, C. Sengupta (Kolkata, India)

Meeting: 2016 International Congress

Abstract Number: 1474

Keywords: Parkinsonism, Psychosis

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Psychiatric manifestations

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To compare prevalence of psychosis in Parkinson’s disease (PD) using the NINDS-NIMH and standard criteria (hallucinations and / or delusions).

Background: The prevalence of Psychosis in Parkinson’s disease (PD) varies between 10-60% across studies due to variability in diagnostic criteria used. Some studies have included vivid dreams, sense of presence, illusions as psychotic symptoms along with delusions and hallucinations. Interestingly the new diagnostic criteria for PD associated Psychosis proposed by the National Institute of Neurological Disorder and Stroke- National Institute of Mental Health (NINDS – NIMH) includes “minor psychotic symptoms” (sense of presence and illusions) along with the “major psychotic symptoms”.

Methods: 200 consecutive consenting patients with PD, fulfilling UK Brain Bank Criteria attending a Neuro-speciality hospital in Eastern India were evaluated with the Unified Parkinson’s disease Rating Scale (UPDRS), Modified Hoehn and Yahr staging, Schwab and England Activities of Daily Living Scale, the Mini International Neuropsychiatric Inventory (M.I.N.I), the National Institute of Neurological Disorder and Stroke- National Institute of Mental Health (NINDS – NIMH) criteria, Mini Mental State Examination (MMSE) and Patient Health Questionnaire 9 (PHQ9).

Results: Psychosis was reported in 26.5% (N=53) and 34% (N= 68) patients using standard criteria and NINDS-NIMH criteria respectively. 31.5% (N=63) patients had no psychiatric illness. 7.5% (N=15) patients with psychosis had “minor psychotic symptoms” only. Patients with minor psychotic symptoms reported significantly higher treatment complications (dyskinesia and clinical fluctuations) as compared to patients with no psychiatric illness. When compared to patients with major psychotic symptoms they were on significantly lower levodopa equivalent doses and less likely to have anorexia, sleep disturbances and depressive symptoms.

Conclusions: The study highlights the need to identify patients with PD having minor psychotic symptoms as they possibly form a distinct subgroup.

To cite this abstract in AMA style:

A. Dutt, H. Kumar, M. Mukherjee, M.U. Kulsum, C. Sengupta. Parkinson’s disease associated psychosis: Prevalence and risk factors [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/parkinsons-disease-associated-psychosis-prevalence-and-risk-factors/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsons-disease-associated-psychosis-prevalence-and-risk-factors/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley